Barriers, facilitators and pathways of a lung cancer screening (LCS) programme: COBELT co-design

Abstract Lung cancer (LC) is one of the most common causes death globally. Adults aged 55+, (ex)-smokers and living in areas deprivation are at greater risk from lung cancer. Leading to a 20% decrease mortality rates, screening with Low Dose CT (LDCT) promising means detecting LC early. Autoantibody biomarker blood tests may play role identifying people suitable for LDCT screening, forming national LCS programme. To increase likelihood success such programme, ways providing service must firstly be identified. A 2-phase co-design process, 2 population groups. Group 1-Aged (ex)-smoker, high (N = 39). 2-Health community professionals 16). Phase 1: Interviews focus Conversations focussed on barriers, facilitators potential pathways uptake provision test LCS. 2: Interactive surveys (offline/online), focussing prioritisation key barriers solution generation. Qualitative data was transcribed analysed using thematic analysis. Descriptive statistics were generated quantitative data. 1 identified provision. Service users indicated options embed programme as essential. From perspective providers, capacity time key. found home kit preferred method (independently or assistance). providers leaned towards via venesection. Barriers ranked by users, dominant barrier Fear result. Working collaborative manner has led identification new knowledge insights regarding best target future those who benefit most. Future implementation should consider results this study. This CSO funded project. Key messages process illuminated pathway that could improve an autoantibody identify candidates. Measures overcome both necessary ensure